Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension
NCT ID: NCT03388476
Last Updated: 2022-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
500 participants
OBSERVATIONAL
2018-05-02
2035-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension
NCT02789449
Pulmonary Hypertension in Hypersensitivity Pneumonitis
NCT03030807
Endothelial Cell Dysfunction in Pulmonary Hypertension
NCT00098072
Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism
NCT07241130
The Early Recognition of Pulmonary Arterial Hypertension
NCT00609349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients which have the probably diagnosis pulmonary hypertension and are older than 18 years are investigated. This patients will get an right heart catheterization and a measurement from their exhaled air.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suspicion of pulmonary hypertension
At Patients with suspicion of pulmonary hypertension, which get a right heart catheterization, in the context of the study the exhaled air, precious the endtidal carbon dioxide (CO2), before or after the right heart catheterization will be measured through capnography.
Capnography
Measuring of the exhaled air, especially endtidal co2, through capnography.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capnography
Measuring of the exhaled air, especially endtidal co2, through capnography.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Giessen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sophie Herbst
Study Chair: Ghofrani H. Ardeschir, Prof. Dr. University of Giessen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henning Gall, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Clinic Giessen and Marburg - Campus Giessen
Werner Seeger, Prof.
Role: STUDY_DIRECTOR
University Clinic Giessen and Marburg
Ardeschir Ghofrani, Prof.
Role: STUDY_DIRECTOR
University Clinic Giessen and Marburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Clinic Giessen and Marburg
Giessen, Hesse, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest. 2011 Nov;140(5):1267-1273. doi: 10.1378/chest.11-0155. Epub 2011 May 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DRKS00013589
Identifier Type: REGISTRY
Identifier Source: secondary_id
AZ 156/17
Identifier Type: OTHER
Identifier Source: secondary_id
AZ 156/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.